1
|
Farid N, Bux K, Ali K, Bashir A, Tahir R. Repurposing Amphotericin B: anti-microbial, molecular docking and molecular dynamics simulation studies suggest inhibition potential of Amphotericin B against MRSA. BMC Chem 2023; 17:67. [PMID: 37386581 DOI: 10.1186/s13065-023-00980-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Accepted: 06/21/2023] [Indexed: 07/01/2023] Open
Abstract
Amphotericin B (AMPH) is an anti-fungal drug and this study, for the first time as best of our knowledge, reports the repurposing of the Amphotericin B. The drug was found to show significant antibacterial potential revealed by antimicrobial screening, molecular docking, and mode of action analysis targeting Penicillin Binding Protein 2a (PBP 2a protein) which is target of β-lactam drugs and is involved in cell wall synthesis. Mode of action analysis showed the drug to have hydrophobic and hydrophilic interactions with both C-terminal, trans-peptidase and non-penicillin binding domain of the protein. Additionally, to evaluate the impact of ligand binding on the protein's conformational dynamics, molecular dynamics (MD) simulations were used. Comparative Dynamical flexibility (RMSF) and Dynamics Cross Correlation (DCCM) followed by MD simulations revealed the complex formation significantly effecting structural dynamics of the enzyme significantly in the non-penicillin binding domain (327-668) and slightly in trans peptidase domain. Radius of gyration assessment further showed ligand binding also decreasing over all compactness of protein. Secondary structure analysis indicated the complex formation changing the conformational integrity in non-penicillin binding domain. Hydrogen bond analysis and MMPBSA, free energy of calculations followed by MD simulations, also complemented the antimicrobial and molecular docking revelations suggesting Amphotericin B to have substantial antibacterial potential.
Collapse
Affiliation(s)
- Neha Farid
- Department of Biosciences, Faculty of Life Sciences, Shaheed Zulfikar Ali Bhutto Institute of Science and Technology (SZABIST), Karachi, Pakistan.
| | - Khair Bux
- Department of Biosciences, Faculty of Life Sciences, Shaheed Zulfikar Ali Bhutto Institute of Science and Technology (SZABIST), Karachi, Pakistan.
| | - Kashif Ali
- Department of Biosciences, Faculty of Life Sciences, Shaheed Zulfikar Ali Bhutto Institute of Science and Technology (SZABIST), Karachi, Pakistan
| | - Asma Bashir
- Department of Biosciences, Faculty of Life Sciences, Shaheed Zulfikar Ali Bhutto Institute of Science and Technology (SZABIST), Karachi, Pakistan
| | - Rahima Tahir
- Department of Biosciences, Faculty of Life Sciences, Shaheed Zulfikar Ali Bhutto Institute of Science and Technology (SZABIST), Karachi, Pakistan
| |
Collapse
|
2
|
Nicholls-Dempsey L, Talsmat H, Soglio DD, Patey N, Tahir R, Dahdouh E, Sylvestre C, Saumet J. Pregnancy outcomes in women with recurrent pregnancy loss and recurrent implantation failure diagnosed with chronic endometritis. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.1057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
3
|
Cotarlan V, Johnson F, Franzwa J, Inampudi C, Emerenini U, Tandon R, Tahir R, Nabeel Y, Goerbig J, Light-McGroary K, Goldsmith G, Giudici M. Biventricular Pacing Has No Acute Hemodynamic Benefit Over Right Ventricular Pacing or Intrinsic Rhythm in LVAD Patients. J Heart Lung Transplant 2017. [DOI: 10.1016/j.healun.2017.01.975] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
4
|
Cutler JA, Tahir R, Sreenivasamurthy SK, Mitchell C, Renuse S, Nirujogi RS, Patil AH, Heydarian M, Wong X, Wu X, Huang TC, Kim MS, Reddy KL, Pandey A. Differential signaling through p190 and p210 BCR-ABL fusion proteins revealed by interactome and phosphoproteome analysis. Leukemia 2017; 31:1513-1524. [DOI: 10.1038/leu.2017.61] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2016] [Revised: 01/04/2017] [Accepted: 01/11/2017] [Indexed: 12/15/2022]
|
5
|
Bassi PU, Osakwe AI, Suku C, Kalat M, Elagbaje C, Isah A, Ayinbuomwan S, Wammanda RD, Bob-Okon II, Ambe J, Mava Y, Adesina AO, Ugochukwu CG, Nyong EE, Ogunleye OO, Onuoha F, Jalo I, Adegoke VO, Balogun ST, Ntadom G, Ejiekpe FN, Tahir R, Dabit K, Amodu AA, Nwaosu S, Habib AT. Cohort event monitoring of patients treated for uncomplicated malaria with artemisinin-based combination therapies in selected hospitals and community pharmacies in Nigeria. Niger Postgrad Med J 2016; 23:172-181. [PMID: 28000637 DOI: 10.4103/1117-1936.196246] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
AIMS AND OBJECTIVES The study was designed with the broad objective of determining the safety profile of artemisinin-based combination therapies amongst Nigerian population. PATIENTS AND METHODS This was a cohort event monitoring (CEM) programme involving monitoring adverse events (AEs) in malaria patients treated with either artemether-lumefantrine (AL) or artesunate-amodiaquine (AA) in healthcare facilities in Nigeria. The study involved continuous enrolment of patients with malaria and treated with either AL or AA at the various sites until a total cohort of 600 patients were enrolled at each site. Patients were monitored from the onset of therapy, and on days 3 and 7 from the first day of treatment to identify AEs that may occur. RESULTS A total of 6102 AEs were recorded in 10,259 patients monitored during the programme. Of 4896 patients who received AA, 4233 (86.5%) patients reported at least one AE while 1869 (34.8%) AEs out of 5363 patients who received AL were reported (P = 0.010). The predominant incidence of each specific AE reported in each group among the patients who received AA and AL includes body weakness 30.8%/7.5%, dizziness 10.3%/3.9%, restlessness 5.02/1.12%, vomiting 3.5/1.03% and drowsiness 3.1/1.5% for AA and AL, respectively. There were more AEs among patients with co-morbid conditions and patients in the younger age groups (9-<15 years), P = 0.000. CONCLUSIONS Various types of AEs were seen and documented during the CEM programme. The findings suggested that the AA/AL monitored during this programme was generally safe and remarkably well tolerated among the Nigerian populations.
Collapse
Affiliation(s)
- P U Bassi
- Department of Pharmacology and Therapeutics, College of Health Sciences, University of Abuja, Abuja, Nigeria
| | - A I Osakwe
- National Agency for Food and Drug Administration and Control, Abuja, Nigeria
| | - C Suku
- National Agency for Food and Drug Administration and Control, Abuja, Nigeria
| | - M Kalat
- National Agency for Food and Drug Administration and Control, Abuja, Nigeria
| | - C Elagbaje
- National Agency for Food and Drug Administration and Control, Abuja, Nigeria
| | - A Isah
- Department of Medicine, Clinical Pharmacology Unit, University of Benin Teaching Hospital, Benin City, Nigeria
| | - S Ayinbuomwan
- Department of Medicine, Clinical Pharmacology Unit, University of Benin Teaching Hospital, Benin City, Nigeria
| | - R D Wammanda
- Department of Paediatrics, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
| | - I I Bob-Okon
- Department of Paediatrics, Federal Medical Centre, Yenagoa, Nigeria
| | - J Ambe
- Department of Paediatrics, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria
| | - Y Mava
- Department of Paediatrics, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria
| | - A O Adesina
- Department of Obstetrics and Gynecology, University College Hospital, Ibadan, Nigeria
| | - C G Ugochukwu
- Department of Paediatrics, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria
| | - E E Nyong
- Department of Paediatrics, University of Uyo Teaching Hospital, Akwa Ibom, Nigeria
| | - O O Ogunleye
- Lagos State University Teaching Hospital, Lagos, Nigeria
| | - F Onuoha
- Federal Medical Centre, Owerri, Nigeria
| | - I Jalo
- Department of Paediatrics, Federal Teaching Hospital, Gombe, Nigeria
| | - V O Adegoke
- NIPRD Research Clinic, National Institute for Pharmaceutical Research and Development, Abuja, Nigeria
| | - S T Balogun
- Department of Clinical Pharmacology and Therapeutics, University of Maiduguri, Maiduguri, Nigeria
| | - G Ntadom
- National Malaria Control Programme, FMoH, Abuja, Nigeria
| | | | - R Tahir
- Rata Pharmacy, Maiduguri, Nigeria
| | - K Dabit
- Skylark Pharmacy, Abuja, Nigeria
| | - A A Amodu
- Federal Medical Center, Makurdi, Nigeria
| | - S Nwaosu
- Department of Mathematics, Federal University of Technology, Makurdi, Nigeria
| | - A T Habib
- Waziri Shehu Specialist Hospital, Kano, Nigeria
| |
Collapse
|
6
|
Wilcox S, Yeo M, Amalaseelan J, Aherne N, Dwyer P, Hansen C, Tahir R, Hill J, McKay M, Shakespeare T. Efficacy of Androgen Deprivation in Combination With Dose-escalated Image Guided Intensity Modulated Radiation Therapy For Prostate Cancer: Five-year Outcomes From a Single Institution. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.1007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
7
|
Tahir R, Ahmed W, Mustafa G, Soofi S, Suhag Z, Bhutta Z, Khan M, Ochiai R, Clemens J, Haq I. The role of an independent entity in equitable access of vaccines in developing countries: A case from Pakistan. Int J Infect Dis 2012. [DOI: 10.1016/j.ijid.2012.05.1016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|